IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a high-purity synthetic peptide designed for advanced research applications involving cellular growth, regeneration pathways, and metabolic signaling studies.
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a modified analog of naturally occurring IGF-1 engineered for enhanced stability and extended biological activity. Due to its reduced binding affinity to IGF binding proteins and prolonged half-life compared to standard IGF-1, IGF-1 LR3 is widely utilized in laboratory research focused on cellular proliferation, tissue regeneration mechanisms, and metabolic signaling pathways.
This research peptide is frequently studied for its interaction with IGF-1 receptors and its role in pathways related to protein synthesis, nutrient utilization, and growth factor signaling. Its structural modifications allow for improved bioavailability in controlled research environments, making it a preferred compound for scientific investigations involving growth factor behavior.
Manufactured under strict quality control standards, IGF-1 LR3 is produced to meet high purity specifications suitable for laboratory and analytical research applications.
• High purity research peptide
• Extended half-life compared to native IGF-1
• Designed for growth factor pathway research
• Stable lyophilized formulation
• Suitable for controlled laboratory studies
This product is intended strictly for research and laboratory use only. Not for human consumption, therapeutic use, or diagnostic purposes. Must be handled by qualified professionals in appropriate research environments.
High-quality research-grade peptides and compounds engineered for scientific innovation and laboratory use.